Delivery Order SPE2DB20D2002-SPE2DB23FL57F
Award Date
7/31/23
Potential Completion Date
8/1/23
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,793,798 units of the drug Mesalamine DR 1.2 GM Tablet 120S, with a ceiling value of $3,303.88. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 4, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.32 firm fixed-price delivery order is for the supply of 120 tablets of the drug Mesalamine DR 1.2 GM. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the...
The federal contract award is for the pharmaceutical product "MESALAMINE DR 1.2 GM TABLET 120S", awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $2,314.88 with a firm fixed price, and has an ultimate completion date of November 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $7,326.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mesalamine delayed-release tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed-price delivery order. This award is not associated with any set-aside...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUYE2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,943,595 tablets of the medication Mesalamine DR 1.2 GM. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,247.15 and an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery...
This federal contract award, valued at $16,619.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560160504 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Mesalamine 800 mg delayed-release tablets. The $13,126.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a period of performance through September 16, 2024 and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,898,250 tablets of Mesalamine delayed-release 1.2 gram tablets. The $2,902.92 Firm Fixed Price contract has a completion date of February 10, 2023 and was awarded on February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award, valued at $64,463.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4566583099 - MESALAMINE 800 MG DR TABLET 180S, with a firm fixed price and an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.47 fixed-price delivery order is for the supply of 4,565,481,647 units of the medication Mesalamine DR 1.2 GM Tablet, with a performance period ending on August 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...